$DOC
HEALTHPEAK PROPERTIES, INC. Stock $doc

$doc Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000162828024043814 Filed on October 25, 2024

Income Statement

Concept	2024 Q4	2024 Q3
Revenue		$700.4M
YoY Change		25.92%
Cost Of Revenue		$280.3M
YoY Change		20.43%
Gross Profit		$420.1M
YoY Change		29.86%
Gross Profit Margin		59.98%
Selling, General & Admin		$23.22M
YoY Change		0.5%
% of Gross Profit		5.53%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$280.0M
YoY Change		51.69%
% of Gross Profit		66.65%
Operating Expenses		$303.2M
YoY Change		30.29%
Operating Profit		$116.9M
YoY Change		28.76%
Interest Expense		$74.11M
YoY Change		46.71%
% of Operating Profit		63.4%
Other Income/Expense, Net		$63.31M
YoY Change		4174.61%
Pretax Income		$98.51M
YoY Change		46.28%
Income Tax		$1.938M
% Of Pretax Income		1.97%
Net Earnings		$85.87M
YoY Change		33.73%
Net Earnings / Revenue		12.26%
Basic Earnings Per Share		$0.12
Diluted Earnings Per Share		$0.12
COMMON SHARES
Basic Shares Outstanding	699.4M shares	699.3M shares
Diluted Shares Outstanding		700.1M shares

Balance Sheet

Concept	2024 Q4	2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments		$180.4M
YoY Change		186.4%
Cash & Equivalents		$180.4M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables		$64.98M
Other Receivables		$0.00
Total Short-Term Assets		$245.4M
YoY Change		101.15%
LONG-TERM ASSETS
Property, Plant & Equipment		$16.32B
YoY Change		22.21%
Goodwill		$65.16M
YoY Change
Intangibles		$898.4M
YoY Change		164.86%
Long-Term Investments		$931.8M
YoY Change		25.08%
Other Assets		$61.62M
YoY Change		4.43%
Total Long-Term Assets		$19.72B
YoY Change		27.41%
TOTAL ASSETS
Total Short-Term Assets		$245.4M
Total Long-Term Assets		$19.72B
Total Assets		$19.97B
YoY Change		27.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$749.9M
YoY Change		178.77%
Accrued Expenses		$308.3M
YoY Change		-16.23%
Deferred Revenue
YoY Change
Short-Term Debt		$0.00
YoY Change
Long-Term Debt Due		$27.49M
YoY Change		-68.04%
Total Short-Term Liabilities		$1.058B
YoY Change		46.36%
LONG-TERM LIABILITIES
Long-Term Debt		$8.583B
YoY Change		30.49%
Other Long-Term Liabilities		$1.106B
YoY Change		-12.76%
Total Long-Term Liabilities		$9.690B
YoY Change		23.5%
TOTAL LIABILITIES
Total Short-Term Liabilities		$1.058B
Total Long-Term Liabilities		$9.690B
Total Liabilities		$10.75B
YoY Change		25.42%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock		$699.4M
YoY Change		27.85%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity		$8.563B
YoY Change
Total Liabilities & Shareholders Equity		$19.97B
YoY Change		27.99%

Cashflow Statement

Concept	2024 Q4	2024 Q3
OPERATING ACTIVITIES
Net Income		$85.87M
YoY Change		33.73%
Depreciation, Depletion And Amortization		$280.0M
YoY Change		51.69%
Cash From Operating Activities		$318.2M
YoY Change		25.62%
INVESTING ACTIVITIES
Capital Expenditures		$174.3M
YoY Change		-7.44%
Acquisitions
YoY Change
Other Investing Activities		$204.5M
YoY Change		-699.78%
Cash From Investing Activities		$30.23M
YoY Change		-113.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		-265.7M
YoY Change		243.26%
NET CHANGE
Cash From Operating Activities		318.2M
Cash From Investing Activities		30.23M
Cash From Financing Activities		-265.7M
Net Change In Cash		82.75M
YoY Change		-277.96%
FREE CASH FLOW
Cash From Operating Activities		$318.2M
Capital Expenditures		$174.3M
Free Cash Flow		$143.9M
YoY Change		121.4%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0000765880
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Registrant Name EntityRegistrantName	Healthpeak Properties, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	33-0091377
	dei	Entity Address Address Line1 EntityAddressAddressLine1	4600 South Syracuse Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 500
	dei	Local Phone Number LocalPhoneNumber	428-5050
	dei	Trading Symbol TradingSymbol	DOC
	dei	Security Exchange Name SecurityExchangeName	NYSE
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	699442979	shares
CY2024Q3	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	16059802000	usd
CY2023Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	13329464000	usd
CY2024Q3	us-gaap	Development In Process DevelopmentInProcess	830310000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	2282000	usd
CY2024Q3	us-gaap	Accounts Receivable Net AccountsReceivableNet	64979000	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	55820000	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	180430000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	117635000	usd
CY2024Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	61615000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	51388000	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	898379000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	314156000	usd
CY2024Q3	us-gaap	Assets Held For Sale Not Part Of Disposal Group AssetsHeldForSaleNotPartOfDisposalGroup	0	usd
CY2023Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group AssetsHeldForSaleNotPartOfDisposalGroup	117986000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	427711000	usd
CY2024Q3	us-gaap	Line Of Credit LineOfCredit	0	usd
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	720000000	usd
CY2024Q3	us-gaap	Loans Payable To Bank LoansPayableToBank	1645748000	usd
CY2023Q4	us-gaap	Loans Payable To Bank LoansPayableToBank	496824000	usd
CY2024Q3	us-gaap	Unsecured Debt UnsecuredDebt	6557170000	usd
CY2023Q4	us-gaap	Unsecured Debt UnsecuredDebt	5403378000	usd
CY2024Q3	us-gaap	Secured Debt SecuredDebt	380459000	usd
CY2023Q4	us-gaap	Secured Debt SecuredDebt	256097000	usd
CY2023Q4	us-gaap	Off Market Lease Unfavorable OffMarketLeaseUnfavorable	127380000	usd
CY2024Q3	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	749881000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	657196000	usd
CY2024Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	903371000	usd
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1.00
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1500000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	699405000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	547156000	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	12844634000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	10405780000	usd
CY2024Q3	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	4968819000	usd
CY2023Q4	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	4621861000	usd
CY2024Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-12381000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	19371000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	8562839000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	6350446000	usd
CY2024Q3	us-gaap	Minority Interest In Joint Ventures MinorityInterestInJointVentures	321949000	usd
CY2023Q4	us-gaap	Minority Interest In Joint Ventures MinorityInterestInJointVentures	310998000	usd
CY2024Q3	us-gaap	Minority Interest In Preferred Unit Holders MinorityInterestInPreferredUnitHolders	335897000	usd
CY2023Q4	us-gaap	Minority Interest In Preferred Unit Holders MinorityInterestInPreferredUnitHolders	214598000	usd
CY2024Q3	us-gaap	Minority Interest MinorityInterest	657846000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	525596000	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9220685000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6876042000	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19969766000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15698850000	usd
CY2024Q3	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	543251000	usd
CY2023Q3	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	417075000	usd
	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	1552065000	usd
	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	1219473000	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	142845000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	133808000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	422512000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	391076000	usd
CY2024Q3	us-gaap	Interest Income Operating InterestIncomeOperating	14301000	usd
	us-gaap	Interest Income Operating InterestIncomeOperating	27884000	usd
	us-gaap	Interest Income Operating InterestIncomeOperating	16802000	usd
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Entity Address City Or Town EntityAddressCityOrTown	Denver
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80237
	dei	City Area Code CityAreaCode	720
	dei	Security12b Title Security12bTitle	Common Stock, $1.00 par value
CY2023Q4	us-gaap	Development In Process DevelopmentInProcess	643217000	usd
CY2024Q3	us-gaap	Land And Land Improvements LandAndLandImprovements	2927675000	usd
CY2023Q4	us-gaap	Land And Land Improvements LandAndLandImprovements	2647633000	usd
CY2024Q3	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	3925375000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	3591951000	usd
CY2024Q3	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	15892412000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	240155000	usd
CY2024Q3	us-gaap	Other Assets OtherAssets	834806000	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	772044000	usd
CY2024Q3	us-gaap	Assets Assets	19969766000	usd
CY2023Q4	us-gaap	Assets Assets	15698850000	usd
CY2024Q3	us-gaap	Off Market Lease Unfavorable OffMarketLeaseUnfavorable	202857000	usd
CY2024Q3	us-gaap	Liabilities Liabilities	10747763000	usd
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	547156311	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	547156311	shares
CY2023Q3	us-gaap	Interest Income Operating InterestIncomeOperating	5360000	usd
	peak	Impairments And Allowance For Credit Loss Reserves Recoveries Net ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet	-156000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	1997185000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	1463081000	usd
CY2023Q3	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	0	usd
	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	187624000	usd
	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	86463000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4208000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	271126000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	90671000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	67342000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	276402000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	254941000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	787000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18364000	usd
CY2024Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3834000	usd
CY2023Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	2101000	usd
	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	24297000	usd
CY2024Q3	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	677590000	usd
CY2024Q3	peak	Liabilities Related To Assets Held For Sale Net LiabilitiesRelatedToAssetsHeldForSaleNet	0	usd
CY2023Q4	peak	Liabilities Related To Assets Held For Sale Net LiabilitiesRelatedToAssetsHeldForSaleNet	729000	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	308277000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	206743000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	905633000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	8773980000	usd
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	48828000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1.00
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	699405171	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	699405171	shares
CY2024Q3	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	1318000	usd
CY2024Q3	us-gaap	Revenues Revenues	700397000	usd
CY2023Q3	us-gaap	Revenues Revenues	556243000	usd
	us-gaap	Revenues Revenues	2002461000	usd
	us-gaap	Revenues Revenues	1627351000	usd
CY2024Q3	us-gaap	Interest Expense InterestExpense	74105000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	50510000	usd
	us-gaap	Interest Expense InterestExpense	209922000	usd
	us-gaap	Interest Expense InterestExpense	147547000	usd
CY2024Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	280019000	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	184559000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	782736000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	561357000	usd
CY2024Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	280279000	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	232734000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	797835000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	677659000	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	23216000	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	23093000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	73233000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	73576000	usd
CY2024Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	7134000	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	122113000	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	3098000	usd
CY2024Q3	peak	Impairments And Allowance For Credit Loss Reserves Recoveries Net ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet	441000	usd
CY2023Q3	peak	Impairments And Allowance For Credit Loss Reserves Recoveries Net ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet	-550000	usd
	peak	Impairments And Allowance For Credit Loss Reserves Recoveries Net ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet	11346000	usd
CY2024Q3	us-gaap	Costs And Expenses CostsAndExpenses	665194000	usd
CY2023Q3	us-gaap	Costs And Expenses CostsAndExpenses	490382000	usd
CY2024Q3	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	62325000	usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	982000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1481000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	83502000	usd
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	63307000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	98510000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2225000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1407000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	6646000	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	92738000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	68656000	usd
	us-gaap	Profit Loss ProfitLoss	256631000	usd
	us-gaap	Profit Loss ProfitLoss	259362000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	6866000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	4442000	usd
	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	18036000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	85872000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	64214000	usd
	us-gaap	Net Income Loss NetIncomeLoss	238595000	usd
	us-gaap	Net Income Loss NetIncomeLoss	235065000	usd
CY2024Q3	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	197000	usd
CY2023Q3	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	166000	usd
	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	610000	usd
	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	1568000	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	85675000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	64048000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	237985000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	233497000	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.36
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.43
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.36
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.43
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	699349000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	547062000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	667536000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	546978000	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	700146000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	547331000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	668096000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	547247000	shares
CY2024Q3	us-gaap	Profit Loss ProfitLoss	92738000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	68656000	usd
	us-gaap	Profit Loss ProfitLoss	256631000	usd
	us-gaap	Profit Loss ProfitLoss	259362000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	-54742000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	5230000	usd
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	-31944000	usd
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	8421000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-64000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-64000	usd
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-192000	usd
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-192000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-54678000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	5294000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-31752000	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	38060000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	73950000	usd
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	224879000	usd
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	267975000	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	6866000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	4442000	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	24297000	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	31194000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	69508000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	206843000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	243678000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9417338000	usd
CY2024Q2	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	1433000	usd
CY2024Q3	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	92788000	usd
CY2024Q3	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	-50000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-54678000	usd
CY2024Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	255000	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	0	usd
CY2024Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	20135000	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4777000	usd
CY2024Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.30
CY2024Q3	us-gaap	Dividends Common Stock DividendsCommonStock	210008000	usd
CY2024Q3	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	9652000	usd
CY2024Q3	peak	Temporary Equity Noncontrolling Interest Decrease From Distributions To Noncontrolling Interest Holders TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	65000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	2830000	usd
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	218450000	usd
CY2024Q1	peak	Loans Receivables Acquired LoansReceivablesAcquired	124000000	usd
	peak	Number Of Loans NumberOfLoans	6	loan
CY2024Q3	peak	Loans And Leases Receivable Remaining Commitments LoansAndLeasesReceivableRemainingCommitments	56000000	usd
CY2024Q3	us-gaap	Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax AociLossCashFlowHedgeCumulativeGainLossAfterTax	-10699000	usd
CY2023Q4	us-gaap	Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax AociLossCashFlowHedgeCumulativeGainLossAfterTax	21245000	usd
CY2024Q3	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	1682000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	1874000	usd
CY2024Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-12381000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	19371000	usd
	peak	Number Of Plan Participants NumberOfPlanParticipants	1	plan_participant
CY2024Q1	peak	Number Of Redeemable Noncontrolling Interest NumberOfRedeemableNoncontrollingInterest	1	interest
CY2024Q2	peak	Number Of Redeemable Noncontrolling Interest With Redemption Conditions NumberOfRedeemableNoncontrollingInterestWithRedemptionConditions	4	property
CY2024Q2	us-gaap	Redeemable Noncontrolling Interest Equity Redemption Value RedeemableNoncontrollingInterestEquityRedemptionValue	53000000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	92738000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	68656000	usd
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	256631000	usd
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	259362000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	6866000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	4442000	usd
	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	18036000	usd
	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	24297000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	85872000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	64214000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	238595000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	235065000	usd
CY2024Q3	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	197000	usd
CY2023Q3	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	166000	usd
	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	610000	usd
	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	1568000	usd
CY2024Q3	peak	Net Income Loss Continuing Operations Available To Common Stockholders Basic NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic	85675000	usd
CY2023Q3	peak	Net Income Loss Continuing Operations Available To Common Stockholders Basic NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic	64048000	usd
	peak	Net Income Loss Continuing Operations Available To Common Stockholders Basic NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic	237985000	usd
	peak	Net Income Loss Continuing Operations Available To Common Stockholders Basic NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic	233497000	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	85675000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	64048000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	237985000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	233497000	usd
CY2024Q3	us-gaap	Dilutive Securities DilutiveSecurities	47000	usd
CY2023Q3	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
	us-gaap	Dilutive Securities DilutiveSecurities	72000	usd
	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	85722000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	64048000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	238057000	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	699349000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	547062000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	667536000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	546978000	shares
CY2024Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	137000	shares
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	269000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	150000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	269000	shares
CY2024Q3	peak	Incremental Common Shares Attributable To Dilutive Effect Of Op Units IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits	660000	shares
	peak	Incremental Common Shares Attributable To Dilutive Effect Of Op Units IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits	410000	shares
	peak	Incremental Common Shares Attributable To Dilutive Effect Of Op Units IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits	0	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	700146000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	547331000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	668096000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	547247000	shares
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.43
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.36
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.43
CY2024Q3	peak	Incremental Common Shares Attributable To Dilutive Effect Of Equity Awards IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards	1000000	shares
	peak	Incremental Common Shares Attributable To Dilutive Effect Of Equity Awards IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards	1000000	shares
CY2023Q3	peak	Incremental Common Shares Attributable To Dilutive Effect Of Equity Awards IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards	1000000	shares
	peak	Incremental Common Shares Attributable To Dilutive Effect Of Equity Awards IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards	1000000	shares
	peak	Incremental Common Shares Attributable To Dilutive Effect Of Op Units Outstanding IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnitsOutstanding	3000000	shares
CY2024Q3	peak	Incremental Common Shares Attributable To Dilutive Effect Of Op Units Outstanding IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnitsOutstanding	3000000	shares
CY2024Q3	peak	Number Of Facilities Owned By Unconsolidated Joint Venture NumberOfFacilitiesOwnedByUnconsolidatedJointVenture	19	property
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	23093000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	13028363000	usd
CY2024Q3	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	9983000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	2830000	usd
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	218450000	usd
CY2024Q3	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	931844000	usd
CY2023Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	782853000	usd
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	2405000	usd
CY2023Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	36000	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1481000	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1938000	usd
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	8613000	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	18036000	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9220685000	usd
CY2024Q3	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	1318000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7061861000	usd
CY2023Q2	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	63792000	usd
CY2023Q3	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	68496000	usd
CY2023Q3	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	160000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	5294000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	328000	usd
CY2023Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	14000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4354000	usd
CY2023Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.30
CY2023Q3	us-gaap	Dividends Common Stock DividendsCommonStock	164299000	usd
CY2023Q3	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	7316000	usd
CY2023Q3	peak	Temporary Equity Noncontrolling Interest Decrease From Distributions To Noncontrolling Interest Holders TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	73000	usd
CY2023Q3	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	173000	usd
CY2023Q3	peak	Temporary Equity Noncontrolling Interest Contributions From Noncontrolling Interest TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest	72000	usd
CY2023Q3	peak	Adjustments Of Permanent Equity To Temporary Equity AdjustmentsOfPermanentEquityToTemporaryEquity	-14935000	usd
CY2023Q3	peak	Temporary Equity Adjustments Of Permanent Equity To Temporary Equity TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity	-14935000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6983812000	usd
CY2023Q3	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	49016000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6876042000	usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	48828000	usd
	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	256538000	usd
	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	93000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-31752000	usd
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	2774147000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	831000	usd
	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	0	usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	190364000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	15286000	usd
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.90
	us-gaap	Dividends Common Stock DividendsCommonStock	585553000	usd
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	27105000	usd
	peak	Temporary Equity Noncontrolling Interest Decrease From Distributions To Noncontrolling Interest Holders TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	377000	usd
	peak	Temporary Equity Noncontrolling Interest Contributions From Noncontrolling Interest TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest	12000	usd
	peak	Temporary Equity Noncontrolling Interest Decrease From Redemptions Or Purchase Of Interests TemporaryEquityNoncontrollingInterestDecreaseFromRedemptionsOrPurchaseOfInterests	52886000	usd
	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	136727000	usd
	peak	Temporary Equity Noncontrolling Interest Increase From Business Combination TemporaryEquityNoncontrollingInterestIncreaseFromBusinessCombination	1536000	usd
	peak	Adjustments Of Permanent Equity To Temporary Equity AdjustmentsOfPermanentEquityToTemporaryEquity	4112000	usd
	peak	Temporary Equity Adjustments Of Permanent Equity To Temporary Equity TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity	4112000	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9220685000	usd
CY2024Q3	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	1318000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7182598000	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	105679000	usd
	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	258889000	usd
	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	473000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	8613000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	685000	usd
	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	0	usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	6488000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	14313000	usd
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.90
	us-gaap	Dividends Common Stock DividendsCommonStock	493884000	usd
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	38316000	usd
	peak	Temporary Equity Noncontrolling Interest Decrease From Distributions To Noncontrolling Interest Holders TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	199000	usd
	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	173000	usd
	peak	Temporary Equity Noncontrolling Interest Contributions From Noncontrolling Interest TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest	292000	usd
	peak	Adjustments Of Permanent Equity To Temporary Equity AdjustmentsOfPermanentEquityToTemporaryEquity	-57229000	usd
	peak	Temporary Equity Adjustments Of Permanent Equity To Temporary Equity TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity	-57229000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6983812000	usd
CY2023Q3	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	49016000	usd
	us-gaap	Profit Loss ProfitLoss	256631000	usd
	us-gaap	Profit Loss ProfitLoss	259362000	usd
	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	782736000	usd
	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	561357000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	11935000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	10966000	usd
	us-gaap	Noncash Merger Related Costs NoncashMergerRelatedCosts	16223000	usd
	us-gaap	Noncash Merger Related Costs NoncashMergerRelatedCosts	0	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	19247000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	8828000	usd
	us-gaap	Straight Line Rent StraightLineRent	32891000	usd
	us-gaap	Straight Line Rent StraightLineRent	12710000	usd
	peak	Amortization Of Nonrefundable Entrance Fees And Above Below Market Lease Intangibles Net AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet	-88925000	usd
	peak	Amortization Of Nonrefundable Entrance Fees And Above Below Market Lease Intangibles Net AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet	-81359000	usd
	peak	Income Loss From Equity Method Investments Including Discontinued Operations IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations	-1407000	usd
	peak	Income Loss From Equity Method Investments Including Discontinued Operations IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations	6646000	usd
	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	11228000	usd
	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	633000	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	11156000	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-1243000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	11346000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	-156000	usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	187624000	usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	86463000	usd
	peak	Gain Loss From Change Of Control GainLossFromChangeOfControl	77548000	usd
	peak	Gain Loss From Change Of Control GainLossFromChangeOfControl	234000	usd
	us-gaap	Insured Event Gain Loss InsuredEventGainLoss	574000	usd
	us-gaap	Insured Event Gain Loss InsuredEventGainLoss	759000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	1652000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-4119000	usd
	us-gaap	Increase Decrease In Accounts Receivable And Other Operating Assets IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets	-2071000	usd
	us-gaap	Increase Decrease In Accounts Receivable And Other Operating Assets IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets	9041000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	52200000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	78340000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	786966000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	724994000	usd
	us-gaap	Payments To Acquire Other Real Estate PaymentsToAcquireOtherRealEstate	4466000	usd
	us-gaap	Payments To Acquire Other Real Estate PaymentsToAcquireOtherRealEstate	15735000	usd
	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	399373000	usd
	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	582494000	usd
	us-gaap	Payments For Leasing Costs Commissions And Tenant Improvements PaymentsForLeasingCostsCommissionsAndTenantImprovements	76744000	usd
	us-gaap	Payments For Leasing Costs Commissions And Tenant Improvements PaymentsForLeasingCostsCommissionsAndTenantImprovements	66264000	usd
	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	619981000	usd
	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	141743000	usd
	peak	Proceeds From Divestiture Of Interest In A Consolidated Subsidiary ProceedsFromDivestitureOfInterestInAConsolidatedSubsidiary	125662000	usd
	peak	Proceeds From Divestiture Of Interest In A Consolidated Subsidiary ProceedsFromDivestitureOfInterestInAConsolidatedSubsidiary	0	usd
	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	54450000	usd
	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	48486000	usd
	peak	Distributions In Excess Of Earnings From Unconsolidated Joint Ventures DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures	20195000	usd
	peak	Distributions In Excess Of Earnings From Unconsolidated Joint Ventures DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures	14980000	usd
	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	6467000	usd
	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	20929000	usd
	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	87259000	usd
	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	184299000	usd
	peak	Payments To Acquire Loans Receivable And Other PaymentsToAcquireLoansReceivableAndOther	25341000	usd
	peak	Payments To Acquire Loans Receivable And Other PaymentsToAcquireLoansReceivableAndOther	10058000	usd
	peak	Cash Cash Equivalents And Restricted Cash Paid As Part Of Mergers CashCashEquivalentsAndRestrictedCashPaidAsPartOfMergers	-179215000	usd
	peak	Cash Cash Equivalents And Restricted Cash Paid As Part Of Mergers CashCashEquivalentsAndRestrictedCashPaidAsPartOfMergers	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	119975000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-361086000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	3146250000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	7799005000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	3866250000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	8370611000	usd
	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	750000000	usd
	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	743778000	usd
	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	3038000	usd
	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	3928000	usd
	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	5438000	usd
	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	7322000	usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	241000	usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	-262000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	190364000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	6488000	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	584964000	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	492937000	usd
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	80368000	usd
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	38515000	usd
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	12000	usd
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	465000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-833919000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-376815000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	73022000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-12907000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	169023000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	126834000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	242045000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	113927000	usd
	us-gaap	Nature Of Operations NatureOfOperations	Business<div style="margin-bottom:6pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Overview</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthpeak Properties, Inc., a Standard & Poor’s 500 company, is a Maryland corporation that is organized to qualify as a real estate investment trust (“REIT”) and that, together with its consolidated entities (collectively, “Healthpeak” or the “Company”), owns, operates, and develops high-quality real estate focused on healthcare discovery and delivery in the United States (“U.S.”). Healthpeak® has a diverse portfolio comprised of investments in the following reportable healthcare segments: (i) outpatient medical; (ii) lab; and (iii) continuing care retirement community (“CCRC”).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s corporate headquarters are in Denver, Colorado, and it has additional corporate offices in California, Tennessee, Wisconsin, and Massachusetts, and property management offices in several locations throughout the U.S.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 10, 2023, the Company completed its corporate reorganization (the “Reorganization”) into an umbrella partnership REIT (“UPREIT”). Substantially all of the Company’s business is conducted through Healthpeak OP, LLC (“Healthpeak OP”). The Company is the managing member of Healthpeak OP and does not have material assets or liabilities, other than through its investment in Healthpeak OP. For additional information on the UPREIT Reorganization, see the Company’s Current Report on Form 8-K12B filed with the U.S. Securities and Exchange Commission (“SEC”) on February 10, 2023.</span></div>On March 1, 2024, the Company completed its planned merger with Physicians Realty Trust (see Note 3).
	peak	Commitments Development And Redevelopment Projects And Tenant Improvements Amount Increase Decrease CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease	27000000	usd
CY2024Q3	peak	Commitments Development And Redevelopment Projects And Tenant Improvements CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements	206000000	usd
CY2024Q3	peak	Properties Held For Sale Number PropertiesHeldForSaleNumber	0	property
CY2024Q3	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
CY2023Q3	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
CY2024Q3	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	394263000	usd
CY2023Q3	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	317106000	usd
	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	1141901000	usd
	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	923285000	usd
CY2024Q3	us-gaap	Operating Lease Variable Lease Income OperatingLeaseVariableLeaseIncome	148988000	usd
CY2023Q3	us-gaap	Operating Lease Variable Lease Income OperatingLeaseVariableLeaseIncome	99969000	usd
	us-gaap	Operating Lease Variable Lease Income OperatingLeaseVariableLeaseIncome	410164000	usd
	us-gaap	Operating Lease Variable Lease Income OperatingLeaseVariableLeaseIncome	296188000	usd
CY2024Q3	peak	Initial Direct Costs Net InitialDirectCostsNet	188000000	usd
CY2023Q4	peak	Initial Direct Costs Net InitialDirectCostsNet	172000000	usd
CY2024Q3	peak	Straight Line Rent Receivable Net Of Allowances StraightLineRentReceivableNetOfAllowances	329000000	usd
CY2023Q4	peak	Straight Line Rent Receivable Net Of Allowances StraightLineRentReceivableNetOfAllowances	310000000	usd
CY2023Q2	us-gaap	Litigation Settlement Amount Awarded From Other Party LitigationSettlementAmountAwardedFromOtherParty	2000000	usd
CY2023Q2	us-gaap	Proceeds From Legal Settlements ProceedsFromLegalSettlements	2000000	usd
CY2024Q3	peak	Operating Lease Area Of Square Feet Renewed OperatingLeaseAreaOfSquareFeetRenewed	2000000	squarefeet
CY2024Q2	peak	Operating Lease Percentage Of Annual Lease Escalations OperatingLeasePercentageOfAnnualLeaseEscalations	0.025
CY2024Q3	peak	Operating Lease Percentage Of Annual Lease Escalations OperatingLeasePercentageOfAnnualLeaseEscalations	0.030
CY2024Q3	peak	Operating Lease Area Of Square Feet With Early Termination Right OperatingLeaseAreaOfSquareFeetWithEarlyTerminationRight	200000	sqft
CY2024Q3	us-gaap	Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount	-24274000	usd
CY2023Q4	us-gaap	Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount	-131000	usd
CY2024Q3	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	9983000	usd
CY2024Q3	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	677590000	usd
CY2024Q3	peak	Loans And Leases Receivable Remaining Commitments LoansAndLeasesReceivableRemainingCommitments	56000000	usd
CY2024Q3	us-gaap	Receivable With Imputed Interest Discount ReceivableWithImputedInterestDiscount	4000000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	2830000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	8280000	usd
	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	7153000	usd
CY2023	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	2088000	usd
	us-gaap	Financing Receivable Excluding Accrued Interest Sale And Reclassification To Held For Sale FinancingReceivableExcludingAccruedInterestSaleAndReclassificationToHeldForSale	0	usd
CY2023	us-gaap	Financing Receivable Excluding Accrued Interest Sale And Reclassification To Held For Sale FinancingReceivableExcludingAccruedInterestSaleAndReclassificationToHeldForSale	7538000	usd
CY2024Q3	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	9983000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	2830000	usd
CY2024Q3	peak	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest Unfunded Loan Commitments FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestUnfundedLoanCommitments	4900000	usd
CY2023Q4	peak	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest Unfunded Loan Commitments FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestUnfundedLoanCommitments	700000	usd
CY2024Q3	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	931844000	usd
CY2023Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	782853000	usd
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	78000000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1495839000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	739228000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	597460000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	425072000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	898379000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	314156000	usd
	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P5Y
CY2023	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P5Y
CY2024Q3	peak	Lease Up Intangible Assets Gross LeaseUpIntangibleAssetsGross	1450000000	usd
CY2023Q4	peak	Lease Up Intangible Assets Gross LeaseUpIntangibleAssetsGross	725000000	usd
CY2024Q3	peak	Above Market Lease Intangible Assets Gross AboveMarketLeaseIntangibleAssetsGross	47000000	usd
CY2023Q4	peak	Above Market Lease Intangible Assets Gross AboveMarketLeaseIntangibleAssetsGross	14000000	usd
CY2024Q3	peak	Lease Up Intangible Assets Accumulated Depreciation And Amortization LeaseUpIntangibleAssetsAccumulatedDepreciationAndAmortization	586000000	usd
CY2023Q4	peak	Lease Up Intangible Assets Accumulated Depreciation And Amortization LeaseUpIntangibleAssetsAccumulatedDepreciationAndAmortization	418000000	usd
CY2024Q3	peak	Above Market Lease Intangible Assets Accumulated Depreciation And Amortization AboveMarketLeaseIntangibleAssetsAccumulatedDepreciationAndAmortization	11000000	usd
CY2023Q4	peak	Above Market Lease Intangible Assets Accumulated Depreciation And Amortization AboveMarketLeaseIntangibleAssetsAccumulatedDepreciationAndAmortization	7000000	usd
CY2024Q3	peak	Finite Lived Intangible Liabilities Gross FiniteLivedIntangibleLiabilitiesGross	354575000	usd
CY2023Q4	peak	Finite Lived Intangible Liabilities Gross FiniteLivedIntangibleLiabilitiesGross	228105000	usd
CY2024Q3	peak	Finite Lived Intangible Liabilities Accumulated Amortization FiniteLivedIntangibleLiabilitiesAccumulatedAmortization	151718000	usd
CY2023Q4	peak	Finite Lived Intangible Liabilities Accumulated Amortization FiniteLivedIntangibleLiabilitiesAccumulatedAmortization	100725000	usd
CY2024Q3	peak	Finite Lived Intangible Liabilities Net FiniteLivedIntangibleLiabilitiesNet	202857000	usd
CY2023Q4	peak	Finite Lived Intangible Liabilities Net FiniteLivedIntangibleLiabilitiesNet	127380000	usd
	peak	Acquired Finite Lived Intangible Liabilities Weighted Average Useful Life AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife	P9Y
CY2023	peak	Acquired Finite Lived Intangible Liabilities Weighted Average Useful Life AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife	P7Y
CY2024Q1	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	891000000	usd
CY2024Q1	peak	Finite Lived Intangible Liabilities Lease FiniteLivedIntangibleLiabilitiesLease	852000000	usd
CY2024Q1	peak	Above Market Lease Intangibles AboveMarketLeaseIntangibles	39000000	usd
CY2024Q1	peak	Finite Lived Intangible Liabilities Acquired FiniteLivedIntangibleLiabilitiesAcquired	150000000	usd
CY2024Q1	peak	Intangible Assets Weighted Average Amortization Useful Life IntangibleAssetsWeightedAverageAmortizationUsefulLife	P6Y
CY2024Q1	peak	Intangible Liabilities Weighted Average Amortization Useful Life IntangibleLiabilitiesWeightedAverageAmortizationUsefulLife	P9Y
CY2023	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	500000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	47000000	usd
CY2024Q3	us-gaap	Goodwill Goodwill	65163000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	18027000	usd
CY2024Q1	peak	Debt Costs Capitalized DebtCostsCapitalized	1000000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	27489000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	803684000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	994999000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	1350842000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	1252775000	usd
CY2024Q3	peak	Long Term Debt Maturity After Year Four LongTermDebtMaturityAfterYearFour	4300000000	usd
CY2024Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	8729789000	usd
CY2024Q3	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	146412000	usd
CY2024Q3	us-gaap	Long Term Debt LongTermDebt	8583377000	usd
CY2023Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.30
CY2024Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.30
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.90
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.90
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	233497000	usd
CY2023Q3	peak	Incremental Common Shares Attributable To Dilutive Effect Of Op Units IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits	0	shares
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.36
CY2024Q3	peak	Reconciliation Of Operating Profit Loss From Segments To Consolidated Non Cash Adjustments ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments	27825000	usd
CY2024Q3	us-gaap	Interest Income Operating InterestIncomeOperating	14301000	usd
CY2024Q3	us-gaap	Interest Expense InterestExpense	74105000	usd
CY2024Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	280019000	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	23216000	usd
CY2024Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	7134000	usd
CY2024Q3	peak	Impairments And Allowance For Credit Loss Reserves ImpairmentsAndAllowanceForCreditLossReserves	441000	usd
CY2024Q3	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	62325000	usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	982000	usd
CY2024Q3	peak	Net Income Loss Joint Venture Partners Attributable To Parent NetIncomeLossJointVenturePartnersAttributableToParent	-7664000	usd
CY2024Q3	us-gaap	Noncontrolling Interest In Net Income Loss Joint Venture Partners Nonredeemable NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable	-6883000	usd
CY2023Q3	peak	Reconciliation Of Operating Profit Loss From Segments To Consolidated Non Cash Adjustments ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments	13389000	usd
CY2023Q3	us-gaap	Interest Income Operating InterestIncomeOperating	5360000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	50510000	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	184559000	usd
CY2023Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	36000	usd
CY2023Q3	peak	Impairments And Allowance For Credit Loss Reserves ImpairmentsAndAllowanceForCreditLossReserves	-550000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1481000	usd
CY2023Q3	peak	Net Income Loss Joint Venture Partners Attributable To Parent NetIncomeLossJointVenturePartnersAttributableToParent	-1912000	usd
CY2023Q3	us-gaap	Noncontrolling Interest In Net Income Loss Joint Venture Partners Nonredeemable NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable	-6382000	usd
	peak	Reconciliation Of Operating Profit Loss From Segments To Consolidated Non Cash Adjustments ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments	80842000	usd
	us-gaap	Interest Income Operating InterestIncomeOperating	27884000	usd
	us-gaap	Interest Expense InterestExpense	209922000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	782736000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	73233000	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	122113000	usd
	peak	Impairments And Allowance For Credit Loss Reserves ImpairmentsAndAllowanceForCreditLossReserves	11346000	usd
	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	187624000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	83502000	usd
	peak	Net Income Loss Joint Venture Partners Attributable To Parent NetIncomeLossJointVenturePartnersAttributableToParent	-20068000	usd
	us-gaap	Noncontrolling Interest In Net Income Loss Joint Venture Partners Nonredeemable NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable	-20207000	usd
	peak	Reconciliation Of Operating Profit Loss From Segments To Consolidated Non Cash Adjustments ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments	37670000	usd
	us-gaap	Interest Income Operating InterestIncomeOperating	16802000	usd
	us-gaap	Interest Expense InterestExpense	147547000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	561357000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	73576000	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	3098000	usd
	peak	Impairments And Allowance For Credit Loss Reserves ImpairmentsAndAllowanceForCreditLossReserves	-156000	usd
	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	86463000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4208000	usd
	peak	Interest Income Excluded From Adjusted Government Grant Income From Continuing Operations InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations	-184000	usd
	peak	Net Income Loss Joint Venture Partners Attributable To Parent NetIncomeLossJointVenturePartnersAttributableToParent	-4882000	usd
	us-gaap	Noncontrolling Interest In Net Income Loss Joint Venture Partners Nonredeemable NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable	-19228000	usd
CY2024Q3	us-gaap	Interest Income Operating InterestIncomeOperating	14301000	usd
CY2023Q3	us-gaap	Interest Income Operating InterestIncomeOperating	5360000	usd
	us-gaap	Interest Income Operating InterestIncomeOperating	27884000	usd
	us-gaap	Interest Income Operating InterestIncomeOperating	16802000	usd
CY2024Q3	us-gaap	Revenues Revenues	700397000	usd
CY2023Q3	us-gaap	Revenues Revenues	556243000	usd
	us-gaap	Revenues Revenues	2002461000	usd
	us-gaap	Revenues Revenues	1627351000	usd
	us-gaap	Interest Paid Net InterestPaidNet	204858000	usd
	us-gaap	Interest Paid Net InterestPaidNet	151753000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	6820000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1258000	usd
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	48446000	usd
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	42879000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	15406000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1160000	usd
	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	120543000	usd
	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	116931000	usd
	us-gaap	Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1 NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1	0	usd
	us-gaap	Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1 NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1	993000	usd
	peak	Noncash Or Part Noncash Retained Investments In Connection With Joint Ventures NoncashOrPartNoncashRetainedInvestmentsInConnectionWithJointVentures	69255000	usd
	peak	Noncash Or Part Noncash Retained Investments In Connection With Joint Ventures NoncashOrPartNoncashRetainedInvestmentsInConnectionWithJointVentures	0	usd
	peak	Non Cash Assets And Liabilities Assumed In Connection With The Mergers NonCashAssetsAndLiabilitiesAssumedInConnectionWithTheMergers	2927611000	usd
	peak	Non Cash Assets And Liabilities Assumed In Connection With The Mergers NonCashAssetsAndLiabilitiesAssumedInConnectionWithTheMergers	0	usd
	peak	Seller Financing Provided On Dispositionof Real Estate Asset SellerFinancingProvidedOnDispositionofRealEstateAsset	404598000	usd
	peak	Seller Financing Provided On Dispositionof Real Estate Asset SellerFinancingProvidedOnDispositionofRealEstateAsset	0	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	117635000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	72032000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	51388000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	54802000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	169023000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	126834000	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	180430000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	63478000	usd
CY2024Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	61615000	usd
CY2023Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	50449000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	242045000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	113927000	usd
	us-gaap	Asset At Fair Value Changes In Fair Value Resulting From Changes In Assumptions AssetAtFairValueChangesInFairValueResultingFromChangesInAssumptions	59000000	usd
CY2024Q3	us-gaap	Number Of Interest Rate Derivatives Held NumberOfInterestRateDerivativesHeld	1	derivative_held
CY2024Q3	us-gaap	Derivative Asset Notional Amount DerivativeAssetNotionalAmount	180000000	usd
CY2024Q3	peak	Refundable Entrance Fees Current And Noncurrent RefundableEntranceFeesCurrentAndNoncurrent	241667000	usd
CY2023Q4	peak	Refundable Entrance Fees Current And Noncurrent RefundableEntranceFeesCurrentAndNoncurrent	251874000	usd
CY2024Q3	us-gaap	Construction Payable Current And Noncurrent ConstructionPayableCurrentAndNoncurrent	120543000	usd
CY2023Q4	us-gaap	Construction Payable Current And Noncurrent ConstructionPayableCurrentAndNoncurrent	105572000	usd
CY2024Q3	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	57928000	usd
CY2023Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	59492000	usd
CY2024Q3	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	329743000	usd
CY2023Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	240258000	usd
CY2024Q3	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	749881000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	657196000	usd
	us-gaap	Severance Costs1 SeveranceCosts1	5000000	usd
CY2023	us-gaap	Severance Costs1 SeveranceCosts1	8000000	usd
CY2024Q3	peak	Nonrefundable Entrance Fees NonrefundableEntranceFees	592576000	usd
CY2023Q4	peak	Nonrefundable Entrance Fees NonrefundableEntranceFees	562026000	usd
CY2024Q3	peak	Other Deferred Revenue OtherDeferredRevenue	310795000	usd
CY2023Q4	peak	Other Deferred Revenue OtherDeferredRevenue	343607000	usd
CY2024Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	903371000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	905633000	usd
CY2024Q3	peak	Proceeds From Collection Of Nonrefundable Entrance Fees ProceedsFromCollectionOfNonrefundableEntranceFees	34000000	usd
	peak	Proceeds From Collection Of Nonrefundable Entrance Fees ProceedsFromCollectionOfNonrefundableEntranceFees	96000000	usd
CY2024Q3	peak	Amortization Of Nonrefundable Entrance Fee AmortizationOfNonrefundableEntranceFee	23000000	usd
	peak	Amortization Of Nonrefundable Entrance Fee AmortizationOfNonrefundableEntranceFee	66000000	usd
CY2023Q3	peak	Proceeds From Collection Of Nonrefundable Entrance Fees ProceedsFromCollectionOfNonrefundableEntranceFees	36000000	usd
	peak	Proceeds From Collection Of Nonrefundable Entrance Fees ProceedsFromCollectionOfNonrefundableEntranceFees	96000000	usd
CY2023Q3	peak	Amortization Of Nonrefundable Entrance Fee AmortizationOfNonrefundableEntranceFee	21000000	usd
	peak	Amortization Of Nonrefundable Entrance Fee AmortizationOfNonrefundableEntranceFee	61000000	usd
CY2024Q3	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	13000000	usd
	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	40000000	usd
CY2023Q3	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	19000000	usd
	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	50000000	usd
CY2024Q2	peak	Number Of Redeemable Noncontrolling Interest With Redemption Conditions NumberOfRedeemableNoncontrollingInterestWithRedemptionConditions	4	property
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false

Files In Submission

Name	View Source	Status
0001628280-24-043814-index-headers.html	Edgar Link	pending
0001628280-24-043814-index.html	Edgar Link	pending
0001628280-24-043814.txt	Edgar Link	pending
0001628280-24-043814-xbrl.zip	Edgar Link	pending
ex31109302024.htm	Edgar Link	pending
ex31209302024.htm	Edgar Link	pending
ex32109302024.htm	Edgar Link	pending
ex32209302024.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
peak-20240930.htm	Edgar Link	pending
peak-20240930.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
peak-20240930_def.xml	Edgar Link	unprocessable
peak-20240930_pre.xml	Edgar Link	unprocessable
peak-20240930_htm.xml	Edgar Link	completed
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
peak-20240930_cal.xml	Edgar Link	unprocessable
peak-20240930_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DOC
HEALTHPEAK PROPERTIES, INC. Stock $doc

2024 Q4 Form 10-Q Financial Statement

#000162828024043814 Filed on October 25, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DOC HEALTHPEAK PROPERTIES, INC. Stock $doc

2024 Q4 Form 10-Q Financial Statement

#000162828024043814 Filed on October 25, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DOC
HEALTHPEAK PROPERTIES, INC. Stock $doc